Error: Could not add to watchlist. X

Audeo Oncology Inc

+ Watchlist
0602211D:AU
ASE
Pending Listing
0602211D:AU is pending Listing
AUD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (AUD)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Audeo Oncology, Inc. is a late stage biopharmaceutical company primarily focused on utilizing Hyaluronic Acid Chemotransport Technology, or HyACT, to target cancer drugs preferentially to tumor cells to enhance drug activity.
ADDRESS
100 Pine Street
Suite 2040
San Francisco, CA 94111
United States
PHONE
415-984-0300
  • Tracey Jean Brown
    VP:Oncology/Chief Scientific Ofcr
  • Wim Meutermans
    VP:Discovery
  • Michael L West
    VP:Intellectual Property
  • Goslik Schepers
    VP:Business Development
Show More